-
-
-
-
-
-
-
Harrow Health (HROW) PT Raised to $70 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harrow Health (HROW)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harrow Health (HROW)
-
-
-
-
-
-
-
Harrow Health (HROW) Misses Q1 EPS by 56c
-
-
-
-
-
-
-
Harrow Health (HROW) ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc.
-
-
-
-
-
-
-
Harrow Health (HROW) Enters into 340B Prime Vendor Program Contract with Apexus for IHEEZO
-
-
-
408,792 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

